
Company valuation, historical trends, and peer comparisons.
According to Roivant Sciences Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 25.12B. This represents a change of 53.36% compared to the average of 16.38B of the last 4 quarters.
The mean historical Enterprise Value of Roivant Sciences Ltd. over the last ten years is 5.75B. The current 25.12B Enterprise Value has changed 336.68% with respect to the historical average. Over the past ten years (40 quarters), ROIV's Enterprise Value was at its highest in in the June 2026 quarter at 24.37B. The Enterprise Value was at its lowest in in the March 2024 quarter at 2.34B.
Average
5.75B
Median
4.70B
Minimum
1.53B
Maximum
17.90B
Discovering the peaks and valleys of Roivant Sciences Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 280.62%
Maximum Annual Enterprise Value = 17.90B
Minimum Annual Increase = -68.14%
Minimum Annual Enterprise Value = 1.53B
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 17.90B | 280.62% |
| 2025 | 4.70B | 120.50% |
| 2024 | 2.13B | -47.52% |
| 2023 | 4.06B | 165.33% |
| 2022 | 1.53B | -68.14% |
| 2021 | 4.81B | -6.01% |
The current Enterprise Value of Roivant Sciences Ltd. (ROIV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.25B
5-year avg
6.07B
10-year avg
5.75B
Roivant Sciences Ltd.’s Enterprise Value is less than Regeneron Pharmaceuticals, Inc. (98.57B), less than Biogen Inc. (43.27B), greater than Incyte Corporation (20.95B), greater than Jazz Pharmaceuticals plc (16.70B), less than Genmab A/S (37.85B), less than Moderna, Inc. (88.15B), greater than Alnylam Pharmaceuticals, Inc. (20.94B), greater than BioNTech SE (10.17B), greater than United Therapeutics Corporation (23.75B), less than Vertex Pharmaceuticals Incorporated (137.62B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 98.57B | $99.52B | |
| 43.27B | $36.78B | |
| 20.95B | $24.19B | |
| 16.70B | $13.91B | |
| 37.85B | $34.00B | |
| 88.15B | $88.59B | |
| 20.94B | $21.44B | |
| 10.17B | $21.95B | |
| 23.75B | $25.55B | |
| 137.62B | $141.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Roivant Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Roivant Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Roivant Sciences Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Roivant Sciences Ltd. (ROIV)?
What is the 3-year average Enterprise Value for Roivant Sciences Ltd. (ROIV)?
What is the 5-year average Enterprise Value for Roivant Sciences Ltd. (ROIV)?
How does the current Enterprise Value for Roivant Sciences Ltd. (ROIV) compare to its historical average?